questionsmedicales.fr
Phénomènes microbiologiques
Phénomènes physiologiques viraux
Réplication virale
Activation virale
Activation virale : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Diagnostic
Infections virales
Tests de diagnostic
Virus
Symptômes
Infections virales
Biopsie
Infections virales
Symptômes
5
Symptômes
Infections virales
Complications
Infections virales
Symptômes
Maladies infectieuses
Prévention
5
Hygiène
Infections virales
Masques
Prévention des maladies
Voyages
Infections virales
Comportements à risque
Infections virales
Traitements
5
Traitement antiviral
Infections virales
Antibiotiques
Infections virales
Vaccins
Prévention des maladies
Complications
5
Complications
Infections virales
Maladies chroniques
Infections virales
Complications
État de santé
Gestion des complications
Infections virales
Facteurs de risque
5
Facteurs de risque
Infections virales
Maladies chroniques
Infections virales
Mode de vie
Infections virales
Stress
Infections virales
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Activation virale : Questions médicales les plus fréquentes",
"headline": "Activation virale : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Activation virale : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-12",
"dateModified": "2025-03-07",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Activation virale"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Réplication virale",
"url": "https://questionsmedicales.fr/mesh/D014779",
"about": {
"@type": "MedicalCondition",
"name": "Réplication virale",
"code": {
"@type": "MedicalCode",
"code": "D014779",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G06.920.925"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Activation virale",
"alternateName": "Virus Activation",
"code": {
"@type": "MedicalCode",
"code": "D014775",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Duncan R Smith",
"url": "https://questionsmedicales.fr/author/Duncan%20R%20Smith",
"affiliation": {
"@type": "Organization",
"name": "Institute of Molecular Biosciences, Mahidol University, Salaya 73170, Thailand."
}
},
{
"@type": "Person",
"name": "Atitaya Hitakarun",
"url": "https://questionsmedicales.fr/author/Atitaya%20Hitakarun",
"affiliation": {
"@type": "Organization",
"name": "Institute of Molecular Biosciences, Mahidol University, Salaya 73170, Thailand."
}
},
{
"@type": "Person",
"name": "Ryosuke Morimoto",
"url": "https://questionsmedicales.fr/author/Ryosuke%20Morimoto",
"affiliation": {
"@type": "Organization",
"name": "Department of Health and Nutrition, Faculty of Human Life Science, Shikoku University, Tokushima 771-1192, Japan."
}
},
{
"@type": "Person",
"name": "Yuji Isegawa",
"url": "https://questionsmedicales.fr/author/Yuji%20Isegawa",
"affiliation": {
"@type": "Organization",
"name": "Department of Applied Biological Chemistry, Graduate School of Agriculture, Osaka Metropolitan University, Sakai, Osaka 599-8531, Japan."
}
},
{
"@type": "Person",
"name": "Janejira Jaratsittisin",
"url": "https://questionsmedicales.fr/author/Janejira%20Jaratsittisin",
"affiliation": {
"@type": "Organization",
"name": "Institute of Molecular Biosciences, Mahidol University, Salaya 73170, Thailand."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "How tumors escape the immune system.",
"datePublished": "2024-05-14",
"url": "https://questionsmedicales.fr/article/38743056",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.7554/eLife.97881"
}
},
{
"@type": "ScholarlyArticle",
"name": "Patterns of immune equilibrium and escape in indolent and progressing tumors.",
"datePublished": "2023-07-06",
"url": "https://questionsmedicales.fr/article/37419120",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ccell.2023.06.003"
}
},
{
"@type": "ScholarlyArticle",
"name": "Correlation of the tumor escape phenotype with loss of PRELP expression in melanoma.",
"datePublished": "2023-09-20",
"url": "https://questionsmedicales.fr/article/37730606",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12967-023-04476-x"
}
},
{
"@type": "ScholarlyArticle",
"name": "Hypoxia-inducible factors: master regulators of hypoxic tumor immune escape.",
"datePublished": "2022-06-03",
"url": "https://questionsmedicales.fr/article/35659268",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s13045-022-01292-6"
}
},
{
"@type": "ScholarlyArticle",
"name": "PPARγ inhibited tumor immune escape by inducing PD-L1 autophagic degradation.",
"datePublished": "2023-04-24",
"url": "https://questionsmedicales.fr/article/37096255",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/cas.15818"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Phénomènes microbiologiques",
"item": "https://questionsmedicales.fr/mesh/D008827"
},
{
"@type": "ListItem",
"position": 3,
"name": "Phénomènes physiologiques viraux",
"item": "https://questionsmedicales.fr/mesh/D018406"
},
{
"@type": "ListItem",
"position": 4,
"name": "Réplication virale",
"item": "https://questionsmedicales.fr/mesh/D014779"
},
{
"@type": "ListItem",
"position": 5,
"name": "Activation virale",
"item": "https://questionsmedicales.fr/mesh/D014775"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Activation virale - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Activation virale",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-15",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Activation virale",
"description": "Comment diagnostiquer une activation virale ?\nQuels tests sont utilisés pour détecter les virus activés ?\nLes symptômes aident-ils au diagnostic ?\nPeut-on détecter un virus inactif ?\nLes biopsies sont-elles utiles pour le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D014775?mesh_terms=Tumor+Escape#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Activation virale",
"description": "Quels sont les symptômes d'une activation virale ?\nLes symptômes varient-ils selon le virus ?\nL'activation virale cause-t-elle des complications ?\nLes symptômes apparaissent-ils rapidement ?\nPeut-on avoir des symptômes sans activation virale ?",
"url": "https://questionsmedicales.fr/mesh/D014775?mesh_terms=Tumor+Escape#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Activation virale",
"description": "Comment prévenir l'activation virale ?\nLe lavage des mains aide-t-il à prévenir les infections ?\nLes masques protègent-ils contre les virus ?\nLes voyages augmentent-ils le risque d'activation virale ?\nLes comportements à risque augmentent-ils l'activation virale ?",
"url": "https://questionsmedicales.fr/mesh/D014775?mesh_terms=Tumor+Escape#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Activation virale",
"description": "Quels traitements existent pour l'activation virale ?\nLes antibiotiques sont-ils efficaces contre les virus ?\nLes vaccins aident-ils à prévenir l'activation virale ?\nComment les antiviraux agissent-ils ?\nLes traitements sont-ils les mêmes pour tous les virus ?",
"url": "https://questionsmedicales.fr/mesh/D014775?mesh_terms=Tumor+Escape#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Activation virale",
"description": "Quelles sont les complications possibles d'une activation virale ?\nL'activation virale peut-elle entraîner des maladies chroniques ?\nLes complications sont-elles prévisibles ?\nLes enfants sont-ils plus à risque de complications ?\nComment gérer les complications d'une activation virale ?",
"url": "https://questionsmedicales.fr/mesh/D014775?mesh_terms=Tumor+Escape#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Activation virale",
"description": "Quels sont les facteurs de risque d'activation virale ?\nL'âge influence-t-il le risque d'activation virale ?\nLes maladies chroniques augmentent-elles le risque ?\nLe mode de vie affecte-t-il le risque d'activation virale ?\nLe stress psychologique influence-t-il le risque ?",
"url": "https://questionsmedicales.fr/mesh/D014775?mesh_terms=Tumor+Escape#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une activation virale ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins et des cultures virales peuvent confirmer l'activation."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour détecter les virus activés ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests PCR et les sérologies sont couramment utilisés pour détecter les virus."
}
},
{
"@type": "Question",
"name": "Les symptômes aident-ils au diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes cliniques orientent souvent vers une activation virale."
}
},
{
"@type": "Question",
"name": "Peut-on détecter un virus inactif ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les tests ne détectent que les virus actifs ou en phase de réplication."
}
},
{
"@type": "Question",
"name": "Les biopsies sont-elles utiles pour le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les biopsies peuvent aider à identifier des infections virales localisées."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une activation virale ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, fatigue, douleurs musculaires et éruptions cutanées sont fréquents."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le virus ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, chaque virus peut provoquer des symptômes spécifiques et variés."
}
},
{
"@type": "Question",
"name": "L'activation virale cause-t-elle des complications ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut entraîner des complications graves comme des pneumonies ou des encéphalites."
}
},
{
"@type": "Question",
"name": "Les symptômes apparaissent-ils rapidement ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent apparaître rapidement ou après une période d'incubation prolongée."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des symptômes sans activation virale ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, d'autres maladies peuvent provoquer des symptômes similaires sans activation virale."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'activation virale ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La vaccination, l'hygiène et l'évitement des contacts sont essentiels."
}
},
{
"@type": "Question",
"name": "Le lavage des mains aide-t-il à prévenir les infections ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un bon lavage des mains réduit le risque de transmission virale."
}
},
{
"@type": "Question",
"name": "Les masques protègent-ils contre les virus ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les masques peuvent réduire la transmission des virus respiratoires."
}
},
{
"@type": "Question",
"name": "Les voyages augmentent-ils le risque d'activation virale ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les voyages peuvent exposer à de nouveaux virus et augmenter le risque."
}
},
{
"@type": "Question",
"name": "Les comportements à risque augmentent-ils l'activation virale ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des comportements comme le partage d'aiguilles augmentent le risque d'infection."
}
},
{
"@type": "Question",
"name": "Quels traitements existent pour l'activation virale ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antiviraux, les immunomodulateurs et les soins de soutien sont utilisés."
}
},
{
"@type": "Question",
"name": "Les antibiotiques sont-ils efficaces contre les virus ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les antibiotiques ne sont pas efficaces contre les infections virales."
}
},
{
"@type": "Question",
"name": "Les vaccins aident-ils à prévenir l'activation virale ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les vaccins peuvent prévenir certaines infections virales et leur activation."
}
},
{
"@type": "Question",
"name": "Comment les antiviraux agissent-ils ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils inhibent la réplication virale, réduisant ainsi la charge virale dans l'organisme."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils les mêmes pour tous les virus ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, chaque virus peut nécessiter un traitement spécifique adapté."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles d'une activation virale ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme la pneumonie, l'encéphalite ou des infections secondaires peuvent survenir."
}
},
{
"@type": "Question",
"name": "L'activation virale peut-elle entraîner des maladies chroniques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines infections virales peuvent provoquer des maladies chroniques comme l'hépatite."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles prévisibles ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être prévisibles selon le virus et l'état de santé de l'hôte."
}
},
{
"@type": "Question",
"name": "Les enfants sont-ils plus à risque de complications ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les enfants peuvent être plus vulnérables à certaines complications virales."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications d'une activation virale ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi médical régulier et des traitements appropriés sont essentiels pour gérer les complications."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque d'activation virale ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'immunodépression, le stress et les voyages fréquents augmentent le risque."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque d'activation virale ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées et les jeunes enfants sont plus à risque."
}
},
{
"@type": "Question",
"name": "Les maladies chroniques augmentent-elles le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme le diabète ou le VIH augmentent le risque d'activation virale."
}
},
{
"@type": "Question",
"name": "Le mode de vie affecte-t-il le risque d'activation virale ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sain peut réduire le risque d'activation virale."
}
},
{
"@type": "Question",
"name": "Le stress psychologique influence-t-il le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut affaiblir le système immunitaire et augmenter le risque d'infection."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 07/03/2025
Contenu vérifié selon les dernières recommandations médicales
5 publications dans cette catégorie
Affiliations :
Institute of Molecular Biosciences, Mahidol University, Salaya 73170, Thailand.
Publications dans "Activation virale" :
4 publications dans cette catégorie
Affiliations :
Institute of Molecular Biosciences, Mahidol University, Salaya 73170, Thailand.
Publications dans "Activation virale" :
3 publications dans cette catégorie
Affiliations :
Department of Health and Nutrition, Faculty of Human Life Science, Shikoku University, Tokushima 771-1192, Japan.
Publications dans "Activation virale" :
3 publications dans cette catégorie
Affiliations :
Department of Applied Biological Chemistry, Graduate School of Agriculture, Osaka Metropolitan University, Sakai, Osaka 599-8531, Japan.
Publications dans "Activation virale" :
3 publications dans cette catégorie
Affiliations :
Institute of Molecular Biosciences, Mahidol University, Salaya 73170, Thailand.
Publications dans "Activation virale" :
3 publications dans cette catégorie
Affiliations :
Institute of Molecular Biosciences, Mahidol University, Salaya 73170, Thailand.
Publications dans "Activation virale" :
3 publications dans cette catégorie
Affiliations :
National Center for Genetic Engineering and Biotechnology (BIOTEC), National Science and Technology Development Agency, Pathum Thani, 12120, Thailand.
Publications dans "Activation virale" :
3 publications dans cette catégorie
Affiliations :
Laboratory of Molecular RNA Virology and Antiviral Strategies, Department of Microbiology, Yong Loo Lin School of Medicine, National University Health System, National University of Singapore, Singapore.
Publications dans "Activation virale" :
3 publications dans cette catégorie
Affiliations :
Laboratory of Molecular RNA Virology and Antiviral Strategies, Department of Microbiology, Yong Loo Lin School of Medicine, National University Health System, National University of Singapore, Singapore; Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore. Electronic address: miccjh@nus.edu.sg.
Publications dans "Activation virale" :
2 publications dans cette catégorie
Affiliations :
Institute of Molecular Biosciences, Mahidol University, Salaya 73170, Thailand.
Publications dans "Activation virale" :
2 publications dans cette catégorie
Affiliations :
Department of Clinical and Biological Sciences, Laboratory of Molecular Virology and Antiviral Research, University of Turin, S. Luigi Gonzaga Hospital, Orbassano Turin, Italy.
Publications dans "Activation virale" :
2 publications dans cette catégorie
Affiliations :
Department of Clinical and Biological Sciences, Laboratory of Molecular Virology and Antiviral Research, University of Turin, S. Luigi Gonzaga Hospital, Orbassano Turin, Italy.
Publications dans "Activation virale" :
2 publications dans cette catégorie
Affiliations :
Department of Clinical and Biological Sciences, Laboratory of Molecular Virology and Antiviral Research, University of Turin, S. Luigi Gonzaga Hospital, Orbassano Turin, Italy.
Publications dans "Activation virale" :
2 publications dans cette catégorie
Affiliations :
Department of Clinical and Biological Sciences, Laboratory of Molecular Virology and Antiviral Research, University of Turin, S. Luigi Gonzaga Hospital, Orbassano Turin, Italy. Electronic address: david.lembo@unito.it.
Publications dans "Activation virale" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh 11451, Kingdom of Saudi Arabia.
Publications dans "Activation virale" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh 11451, Kingdom of Saudi Arabia.
Publications dans "Activation virale" :
2 publications dans cette catégorie
Affiliations :
Centre for Global Health Research, University of Edinburgh, Edinburgh, UK.
Publications dans "Activation virale" :
2 publications dans cette catégorie
Publications dans "Activation virale" :
2 publications dans cette catégorie
Affiliations :
College of Veterinary Medicine, Yangzhou University, Yangzhou, 225009, Jiangsu Province, PR China; Institute of Comparative Medicine, Yangzhou University, Yangzhou, 225009, Jiangsu Province, PR China.
Publications dans "Activation virale" :
2 publications dans cette catégorie
Affiliations :
Animal Infectious Disease Laboratory, College of Veterinary Medicine, Yangzhou University, Yangzhou, 225009, PR China; Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonosis, Yangzhou University, Yangzhou, 225009, Jiangsu Province, PR China.
Publications dans "Activation virale" :
Mutations in the gene for β-catenin cause liver cancer cells to release fewer exosomes, which reduces the number of immune cells infiltrating the tumor....
By comparing indolent/slowly progressing with aggressive/rapidly progressing tumor types, Pandey et al. identify human evidence of immune equilibrium in indolent tumors and immune escape in progressin...
Despite immunotherapies having revolutionized the treatment of advanced cutaneous melanoma, effective and durable responses were only reported in a few patients. A better understanding of the interact...
The structural integrity, expression and function of PRELP, its correlation with the expression of immune modulatory molecules, immune cell infiltration and clinical parameters were determined using s...
Bioinformatics analysis revealed a heterogeneous, but statistically significant reduced PRELP expression in available datasets of skin cutaneous melanoma when compared to adjacent normal tissues, whic...
Our findings suggest that PRELP induces the expression of MHC class I and CCL5 in melanoma, which might be involved in an enhanced T cell recruitment and immunogenicity associated with an improved pat...
Hypoxia, a common feature of the tumor microenvironment in various types of cancers, weakens cytotoxic T cell function and causes recruitment of regulatory T cells, thereby reducing tumoral immunogeni...
Blockade of the programmed death 1 (PD-1)/ programmed death ligand 1 (PD-L1) immune checkpoint could increase antitumor immunotherapy for multiple types of cancer, but the response rate of patients is...
Cancer is an evolutionary process shaped by selective pressure from the microenvironments. However, recent studies reveal that certain tumors undergo neutral evolution where there is no detectable fit...
As a master transcription factor, c-Myc plays an important role in promoting tumor immune escape. In addition, PPARγ (peroxisome proliferator-activated receptor γ) regulates cell metabolism, inflammat...
Tripartite motif (TRIM) family proteins have more than 80 members and are widely found in various eukaryotic cells. Most TRIM family proteins participate in the ubiquitin-proteasome degradation system...
The aim of the review is to make up for the gap in the current research on TRIM family proteins and tumor immune escape and propose future development directions according to the current progress and ...
This up-to-date review summarizes the characteristics and biological functions of TRIM family proteins, discusses the mechanisms of TRIM family proteins involved in tumor immune escape, and highlights...
The infiltration of immune cells and their roles of the infiltrating-immune cells in gastrointestinal stromal tumor (GIST) is still unclear. We aimed to discover the infiltration cell types and the re...
Single-cell RNA sequencing were performed to discover types of the infiltrating-immune cells and to analyze CellChat between cells. Immunohistochemistry of 80 GIST samples were used to clarify the rel...
Tumor cells, macrophages, and T-cells were the predominant cell types. The MIF/CXCR4 axis was the most common ligand-receptor interaction between macrophages and tumor cells. As the risk increased, ex...
These findings identify that macrophages are the most abundant infiltrating cells in GIST. The MIF/CXCR4 axis is the most common ligand-receptor interaction between macrophages and tumor cells. GIST c...
The failure of cancer treatments, including immunotherapy, continues to be a major obstacle in preventing durable remission. This failure often results from tumor evolution, both genotypic and phenoty...